Instalab
logoInstalab

Lambs Quarters Weed IgE

Pinpoint whether lamb's quarters pollen is driving your seasonal allergy symptoms, beyond what a general allergy panel reveals.
4.9 (4,363 reviews)
Tested by DSL or Genova
Physician-reviewed results
How it works
Order from Instalab
No prescription or your own doctor's order needed
Get blood drawn
At home
Get results
Explained with clear next steps, no medical jargon

Should you take a Lambs Quarters Weed IgE test?

This test is most useful if any of these apply to you.

Suffering Through Late Summer Allergies
If your nose, eyes, or chest flare every August through October, this can show whether weed pollen is the trigger.
Living With Seasonal Asthma
Weed pollen sensitization is a known driver of asthma flares, and identifying the specific allergen helps target treatment.
Considering Allergy Shots
Confirming the specific pollen driving your symptoms is the first step in deciding whether allergen immunotherapy makes sense.
A Parent of a Child With Allergies
Pinpointing the specific pollens behind your child's symptoms helps guide avoidance and treatment decisions.

About Lambs Quarters Weed IgE

If your nose runs, your eyes itch, or your asthma flares in late summer and fall, the cause may be hiding in an empty lot or roadside near you. Lamb's quarters (Chenopodium album) is a common weed whose pollen can quietly drive allergic rhinitis and asthma in people who never connect their symptoms to it.

This test measures IgE (immunoglobulin E), an antibody your immune system makes when it tags a substance as an allergen. A positive result means your immune system has been primed to react to lamb's quarters pollen, which can help explain stubborn seasonal symptoms and guide whether allergen-specific treatments make sense for you.

Why Lamb's Quarters Matters as an Allergen

Lamb's quarters belongs to the Chenopodiaceae family, a group of weeds that includes Russian thistle. In an Iranian allergy clinic study of 972 patients, lamb's quarter and Russian thistle were among the most common aeroallergens, with each sensitizing roughly half of patients tested by skin prick. Lamb's quarter produced one of the largest skin reactions of any allergen tested, especially in people with allergic rhinitis.

Sensitization to this pollen rarely travels alone. The same study found strong cross-sensitization between lamb's quarter and Russian thistle, meaning the immune system often reacts to both. If your IgE to lamb's quarters is elevated, there is a good chance other related weeds are also part of the picture.

Allergic Rhinitis and Asthma

Weed pollen IgE sensitization tracks closely with respiratory allergy. In a study of 6,391 European adults, higher levels of allergen-specific IgE to common aeroallergens were tied to a stepwise increase in respiratory symptoms, including asthma-like wheezing and nose-and-eye symptoms on exposure. The higher the IgE concentration, the higher the chance of clinically meaningful symptoms when the allergen is in the air.

What this means for you: a positive lamb's quarters IgE alone does not diagnose allergy. Symptoms during the weed's pollen season are what turn a lab number into a clinical diagnosis. But when symptoms and IgE line up, the test gives you a specific target rather than a vague "seasonal allergy" label.

Cross-Reactivity Within the Weed Family

Pollens within the Chenopodiaceae family share similar protein structures, so antibodies that recognize one often recognize others. Research on Chenopodiaceae-allergic patients found that sensitization to Chenopodium album and Salsola kali (Russian thistle) is highly correlated, but some patients react only to Salsola because of a specific protein called Sal k 1, which is absent from lamb's quarters. Sal k 1 has been proposed as a marker allergen to separate true Salsola-only sensitization from broader Chenopodiaceae allergy when planning immunotherapy.

Lamb's quarters pollen also contains a protein called Che a 2 (a profilin) that shows high IgE cross-reactivity with profilins in many other plants. This can produce a positive lamb's quarters result even when the primary trigger is a different pollen entirely.

The CCD Problem: Why Some Positives Are Not Real

One of the most important caveats in interpreting weed pollen IgE is something called CCDs (cross-reactive carbohydrate determinants), small sugar structures that decorate many plant proteins and can trigger IgE binding without causing real allergy symptoms. In a study of Chinese patients, IgE levels to Chenopodium album, redroot amaranth, and other autumn weeds dropped sharply after CCD inhibition, and many positive results turned negative.

A separate Southern China study of 46 patients showed that 73 to 100 percent of weed and seed food IgE tests turned negative after CCD inhibition. CCD-driven IgE is also common in pollen-allergic children, often arising from grass pollen sensitization. The practical takeaway: a positive lamb's quarters IgE that does not match your symptom pattern may reflect CCD cross-reactivity, not a clinically relevant allergy.

Reference Ranges

Allergen-specific IgE is typically reported in kU/L (a unit measuring antibody concentration in blood). The ranges below come from the widely used class system applied to allergen-specific IgE assays such as ImmunoCAP. They are orientation, not absolutes. Your lab may use slightly different cutpoints, and the clinical meaning of any number depends on whether your symptoms match exposure.

ClassRange (kU/L)What It Suggests
0 (Negative)Less than 0.10No detectable sensitization
1 (Low)0.10 to 0.70Low-level sensitization, often without symptoms
2 (Moderate)0.71 to 3.50Moderate sensitization, symptoms possible on exposure
3 to 4 (High)3.51 to 50.0High sensitization, symptoms likely with exposure
5 to 6 (Very High)Above 50.0Very high sensitization, symptoms very likely

Compare your results within the same lab over time for the most meaningful trend. Different assays do not give identical numbers, and a value that crosses a threshold on one platform may sit on the other side of it on another.

Tracking Your Trend

A single IgE reading is a snapshot. Sensitization patterns can shift over time, especially in children and in adults whose exposures change with where they live or work. Tracking serial results helps you see whether your sensitization is rising, stable, or fading, and whether interventions like avoidance or allergen immunotherapy are shifting the underlying biology.

A reasonable cadence: get a baseline, retest in 6 to 12 months if you start a treatment such as allergen immunotherapy or make a major environmental change, and otherwise recheck every 1 to 2 years if symptoms persist. Trends matter more than any single number.

When Results Can Be Misleading

  • CCD interference: cross-reactive carbohydrate determinants can produce positive results that do not reflect true clinical allergy. If your number does not match your symptom pattern, ask your lab whether CCD inhibition testing is available.
  • Profilin cross-reactivity: the Che a 2 profilin in lamb's quarters cross-reacts with profilins in many plants, so a positive result may reflect sensitization to a different primary pollen.
  • Total IgE elevation: very high total IgE (such as in chronic urticaria or parasitic infection) can produce inconsistent results between total and allergen-specific IgE assays. In a study of 2,139 patients, this kind of inconsistency occurred in about 30 percent of cases, especially in older adults and those with chronic urticaria.
  • Assay variability: allergen-specific IgE values can differ between laboratories. Stick with one lab when tracking trends.

Decision Pathway for an Elevated Result

An elevated lamb's quarters IgE is a starting point, not a verdict. The most useful next step is to compare your seasonal symptom pattern against local lamb's quarters pollen counts. If symptoms align with weed pollen season, the result has real clinical weight. If they do not, the elevation may be CCD-driven or reflect cross-reactivity to another pollen.

Consider pairing this test with IgE to Russian thistle and other Chenopodiaceae weeds, since they often travel together. If you are sensitized to multiple unrelated pollens, component-resolved diagnostics (which use individual purified allergen proteins like Sal k 1) can help identify the primary trigger and guide whether allergen immunotherapy, the only disease-modifying treatment for pollen allergy, is appropriate. An allergist or immunologist is the specialist to involve when results are positive and symptoms are significant.

What Moves This Biomarker

Evidence-backed interventions that affect your Lambs Quarters Weed IgE level

Decrease
Omalizumab (anti-IgE monoclonal antibody)
Omalizumab binds free IgE in the bloodstream and lowers measurable free IgE levels, reducing symptoms in severe allergic asthma and food allergy. In a randomized trial of 180 multifood-allergic participants aged 1 year and older, 16 weeks of omalizumab raised the reaction threshold for major allergens compared with placebo. Effects on lamb's quarters-specific IgE specifically have not been measured directly; this is indirect evidence about the mechanism rather than this allergen.
MedicationStrong Evidence
Up & Down
Allergen-specific immunotherapy (allergy shots or sublingual tablets)
Allergen immunotherapy is the only treatment shown to change the underlying immune response to pollen rather than just suppressing symptoms. IgE to the target allergen typically rises temporarily in the first months of treatment, then declines over years as IgG4 blocking antibodies and immune tolerance develop. Long-term clinical benefit and immune tolerance have been demonstrated for related weed and grass pollens. Trials specifically targeting lamb's quarters extract are limited; most direct evidence comes from grass pollen and ragweed immunotherapy, which involve a related but different allergen.
MedicationModerate Evidence

Frequently Asked Questions

References

12 studies
  1. Shokouhi Shoormasti R, Mahloujirad M, Sabetkish N, Kazemnejad a, Ghobadi Dana V, Tayebi B, Morad Abbasi J, Sadri H, Fazlollahi M, Pourpak Z, Moin MDermatologic Therapy2020
  2. Chen H, Jiang Q, Yang Y, Zhang W, Yang L, Zhu RJournal of Asthma and Allergy2022
  3. Barderas R, García-sellés J, Salamanca G, Colás C, Barber D, Rodríguez R, Villalba MClinical & Experimental Allergy2007
  4. Potapova E, Tripodi S, Panetta V, Dramburg S, Bernardini R, Caffarelli C, Matricardi PClinical & Experimental Allergy2024